NHI Announces $89.2 Million in Investments and Updates Pipeline
MURFREESBORO, TN / ACCESS Newswire / December 18, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has...
Hospitals
RXNT Announces TEFCA Connectivity and Integrated QHIN Access Through Strategic Partnership with Kno2
ANNAPOLIS, Md. and BOISE, Idaho, Dec. 18, 2025 /PRNewswire/ -- RXNT, a leading clinical EHR and Practice Management software company,...
RXNT Announces TEFCA Connectivity and Integrated QHIN Access Through Strategic Partnership with Kno2
ANNAPOLIS, Md. and BOISE, Idaho, Dec. 18, 2025 /PRNewswire/ -- RXNT, a leading clinical EHR and Practice Management software company,...
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® KitTYLER,...
TOMI Environmental Solutions Secures a Purchase Order of Approximately $500,000 for the Integration of SteraMist iHP Technology within a Global Biopharmaceutical Leader
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection...
The Menninger Clinic Announces $1 Million Gift to Establish Adolescent Patient Assistance Fund
New fund expands access to world-class mental health care for adolescents ages 12-17 HOUSTON, TX / ACCESS Newswire / December...
The Menninger Clinic Announces $1 Million Gift to Establish Adolescent Patient Assistance Fund
New fund expands access to world-class mental health care for adolescents ages 12-17 HOUSTON, TX / ACCESS Newswire / December...
Picard Medical Marks Public Company Milestone by Ringing the NYSE Opening Bell
Picard Medical, Inc. / SynCardia Systems LLC commemorate the Company’s transition to the public markets and continued advancement of their...
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of...
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of...
Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients
Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to treatment in...
BC Platforms and GeneVault partner to unlock access to large-scale real-world and genomic data from under-represented populations
Partnership expands BC Platforms' global patient catchment to include an additional 48 million patient lives across Asia, the Middle East,...
DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),...
Catalyst by Wellstar Launches Polysight, Bringing Real-Time AI to Healthcare Compliance
The startup was formed to address rising regulatory complexity in healthcare.ATLANTA, Dec. 17, 2025 /PRNewswire/ -- Catalyst by Wellstar today...
BenCura University: Elevating Care, One Course at a Time
KENNESAW, GA / ACCESS Newswire / December 17, 2025 / Innovation in healthcare doesn't happen by accident, it happens by...
Moon Surgical Unlocks the Intelligent OR with Maestro Connectivity and Insights Activation
PARIS and SAN FRANCISCO, Dec. 17, 2025 /PRNewswire/ -- Moon Surgical announced today that all deployed Maestro systems now feature...
Ultromics Secures Strategic Investment from the American Heart Association’s Go Red for Women Venture Fund™
Funding accelerates Ultromics' work to close one of medicine's most pervasive health-equity gaps: heart failure with preserved ejection fraction (HFpEF),...
Bioptimus Unveils M-Optimus, a World Model for Biology
Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical...
Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare
Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorporation.com PLAINVIEW,...
Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare
Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorporation.com PLAINVIEW,...